Egg White-Based Snack Improves Serum Albumin and Nutritional Intake in CAPD Patients: A Single-Arm Intervention Study

Effect of a High-Protein, Low-Sodium Egg White-Based Nutritional Snack on Serum Albumin and Dietary Intake in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients: A Single-Arm Intervention Study

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

TCTR

Registry ID

TCTR20250727001

Enrollment

Registered

2025-07-27

Start date

2023-10-09

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

End-stage renal disease Peritoneal dialysis Protein-energy wasting Hypoalbuminemia Malnutrition Nutritional supplementation Chronic kidney disease Dietary protein intake Peritoneal Dialysis Renal Insufficiency, Chronic Protein-Energy Malnutrition Dietary Proteins Egg Proteins Nutritional Status Serum Albumin Dietary Supplements

Interventions

Participants received a high-protein, low-sodium egg white-based nutritional product (Egg Bite) as a dietary supplement. Each participant consumed three sachets per day (total 105 g), providing 390 kc

Active Comparator Dietary Supplement

Intervention: Egg Bite

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 18 years or older 2. Diagnosed with end-stage renal disease (ESRD) 3. Undergoing continuous ambulatory peritoneal dialysis (CAPD) for at least 3 months 4. Able to consume oral nutritional supplements 5. Serum albumin level less than or equal to 3.8 g/dL at screening 6. Willing to comply with the 21-day intervention protocol

Exclusion criteria

Exclusion criteria: 1. History of allergy to eggs or egg products 2. Diagnosed with liver cirrhosis or severe hepatic impairment 3. Active infection or hospitalization within the past 1 month 4. Participation in another clinical trial within the past 30 days 5. Pregnant or breastfeeding at the time of enrollment 6. Cognitive impairment or psychiatric disorders interfering with study compliance 7. Uncontrolled diabetes mellitus (fasting plasma glucose >200 mg/dL)

Design outcomes

Primary

Measure	Time frame
Serum albumin concentration, daily protein intake, blood urea nitrogen, prealbumin, hs-CRP Baseline, Day 14, and Day 21 Enzymatic colorimetric method using an automated clinical chemistry analyzer	—

Secondary

Measure	Time frame
body weight, fasting plasma glucose Baseline, Day 14, and Day 21 Enzymatic colorimetric method using an automated clinical chemistry analyzer	—

Countries

Thailand

Contacts

Public ContactWittawas Sajjapong

University of Phayao, School of Medical Sciences, Division of Nutrition and Dietetics

wittawas.sa@up.ac.th054466666

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026